Elsa Azevedo Selected Research

Elsa Azevedo Research Topics

Disease

17	Stroke (Strokes) 03/2024 - 11/2010
8	Ischemic Stroke 10/2021 - 11/2010
5	Cerebral Hemorrhage 10/2021 - 11/2010
2	Hypertension (High Blood Pressure) 09/2022 - 01/2021
2	Hypercapnia 01/2022 - 03/2017
2	Inflammation (Inflammations) 10/2021 - 01/2021
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2021 - 01/2021
2	Diabetes Mellitus 01/2021 - 04/2014
2	Brain Ischemia (Cerebral Ischemia) 01/2020 - 07/2019
2	Syncope (Fainting) 09/2015 - 06/2004
1	Albuminuria 09/2022
1	Chronic Renal Insufficiency 09/2022
1	Cerebral Small Vessel Diseases 09/2022
1	Central Nervous System Vasculitis 04/2022
1	Clinical Deterioration 04/2022
1	Hyperventilation 01/2022
1	Primary angiitis of the central nervous system 12/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2021
1	Brain Edema (Cerebral Edema) 01/2021
1	CADASIL 07/2019
1	Hematoma 11/2018
1	Carotid Stenosis (Carotid Artery Stenosis) 10/2018
1	Atrial Fibrillation 01/2018
1	Hypocapnia 03/2017
1	Disease Progression 01/2017
1	Cognitive Dysfunction 01/2017
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2017
1	Traumatic Intracranial Hemorrhage 01/2017
1	Edema (Dropsy) 01/2017
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2017
1	Dementia (Dementias) 01/2017
1	Infarction (Infarctions) 01/2017
1	Postural Orthostatic Tachycardia Syndrome 09/2015
1	Orthostatic Intolerance 09/2015
1	Drug Resistant Epilepsy 05/2014
1	Isolated Systolic Hypertension 04/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2014
1	Pathologic Constriction (Stenosis) 04/2014
1	Parkinson Disease (Parkinson's Disease) 11/2010
1	Hypovolemia 01/2005
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2005
1	Dizziness (Lightheadedness) 06/2004

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 09/2022 - 09/2015
3	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 01/2021 - 01/2017
3	Vitamin K FDA Link 11/2018 - 01/2017
3	N(4)-oleylcytosine arabinosideIBA 11/2018 - 01/2017
3	AnticoagulantsIBA 11/2018 - 01/2017
2	tocilizumab (atlizumab)FDA Link 04/2022 - 12/2021
2	carbogenIBA 01/2022 - 03/2017
1	SaltsIBA 09/2022
1	Carbon DioxideIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2017
1	Anticonvulsants (Antiepileptic Drugs)IBA 05/2014
1	LDL CholesterolIBA 04/2014
1	Phenobarbital (Luminal)FDA Link 04/2014
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2010
1	Natriuretic PeptidesIBA 01/2005
1	Phytoestrogens (Phytoestrogen)IBA 01/2005
1	Atrial Natriuretic Factor (ANF)IBA 01/2005

Therapy/Procedure

4	Therapeutics 01/2021 - 04/2014
3	Patient Readmission 03/2024 - 01/2020
3	Thrombectomy 09/2020 - 01/2020
1	Punctures 02/2022
1	Immunomodulation 01/2021
1	Length of Stay 01/2020
1	Endarterectomy (Thromboendarterectomy) 10/2018
1	Neurological Rehabilitation 01/2018
1	Deep Brain Stimulation 11/2010
1	Massage (Zone Therapy) 06/2004